220 related articles for article (PubMed ID: 35271694)
1. Predictive Value of Isolated Symptoms for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children Tested During Peak Circulation of the Delta Variant.
Westbrook AL; Benedit LC; Frediani JK; Griffiths MA; Khan NY; Levy JM; Morris CR; Rostad CA; Stone CL; Sullivan J; Vos MB; Welsh J; Wood A; Martin GS; Lam W; Pollock NR
Clin Infect Dis; 2022 Sep; 75(7):1131-1139. PubMed ID: 35271694
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.
Marquez C; Kerkhoff AD; Schrom J; Rojas S; Black D; Mitchell A; Wang CY; Pilarowski G; Ribeiro S; Jones D; Payan J; Manganelli S; Rojas S; Lemus J; Jain V; Chamie G; Tulier-Laiwa V; Petersen M; DeRisi J; Havlir DV
JAMA Netw Open; 2022 Oct; 5(10):e2235844. PubMed ID: 36215069
[TBL] [Abstract][Full Text] [Related]
3. Symptoms associated with a positive result for a swab for SARS-CoV-2 infection among children in Alberta.
King JA; Whitten TA; Bakal JA; McAlister FA
CMAJ; 2021 Jan; 193(1):E1-E9. PubMed ID: 33234533
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection in children evaluated in an ambulatory setting during Delta and Omicron time periods.
Smith H; Mahon A; Moss A; Rao S
J Med Virol; 2023 Jan; 95(1):e28318. PubMed ID: 36397139
[TBL] [Abstract][Full Text] [Related]
5. COVID-19-Related Symptoms during the SARS-CoV-2 Omicron (B.1.1.529) Variant Surge in Japan.
Akaishi T; Kushimoto S; Katori Y; Sugawara N; Egusa H; Igarashi K; Fujita M; Kure S; Takayama S; Abe M; Kikuchi A; Ohsawa M; Ishizawa K; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Ishii T
Tohoku J Exp Med; 2022 Sep; 258(2):103-110. PubMed ID: 36002251
[TBL] [Abstract][Full Text] [Related]
6. Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom.
Vihta KD; Pouwels KB; Peto TEA; Pritchard E; Eyre DW; House T; Gethings O; Studley R; Rourke E; Cook D; Diamond I; Crook D; Matthews PC; Stoesser N; Walker AS;
Clin Infect Dis; 2022 Aug; 75(1):e329-e337. PubMed ID: 34748629
[TBL] [Abstract][Full Text] [Related]
7. Symptoms and Transmission of SARS-CoV-2 Among Children - Utah and Wisconsin, March-May 2020.
Laws RL; Chancey RJ; Rabold EM; Chu VT; Lewis NM; Fajans M; Reses HE; Duca LM; Dawson P; Conners EE; Gharpure R; Yin S; Buono S; Pomeroy M; Yousaf AR; Owusu D; Wadhwa A; Pevzner E; Battey KA; Njuguna H; Fields VL; Salvatore P; O'Hegarty M; Vuong J; Gregory CJ; Banks M; Rispens J; Dietrich E; Marcenac P; Matanock A; Pray I; Westergaard R; Dasu T; Bhattacharyya S; Christiansen A; Page L; Dunn A; Atkinson-Dunn R; Christensen K; Kiphibane T; Willardson S; Fox G; Ye D; Nabity SA; Binder A; Freeman BD; Lester S; Mills L; Thornburg N; Hall AJ; Fry AM; Tate JE; Tran CH; Kirking HL
Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33033178
[TBL] [Abstract][Full Text] [Related]
8. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
9. Symptom monitoring after coronavirus disease 2019 (COVID-19) vaccination in a large integrated healthcare system: Separating symptoms from severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection.
Shenoy ES; Wickner PG; West LR; Banerji A; Blumenthal KG; Centi AJ; Gottlieb A; Hashimoto DM; Kim E; Kim M; Lee H; Simpson LA; Landman AB
Infect Control Hosp Epidemiol; 2022 Oct; 43(10):1439-1446. PubMed ID: 34726142
[TBL] [Abstract][Full Text] [Related]
10. Should COVID-19 symptoms be used to cohort patients in the emergency department? A retrospective analysis.
Bijur PE; Friedman BW; Baron SW; Ramasahayam A; Nerenberg R; Sharpe S; Goldstein DY; Esses D
Am J Emerg Med; 2022 Apr; 54():274-278. PubMed ID: 35220142
[TBL] [Abstract][Full Text] [Related]
11. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.
Elliott J; Whitaker M; Bodinier B; Eales O; Riley S; Ward H; Cooke G; Darzi A; Chadeau-Hyam M; Elliott P
PLoS Med; 2021 Sep; 18(9):e1003777. PubMed ID: 34582457
[TBL] [Abstract][Full Text] [Related]
12. Outbreak of SARS-CoV-2 infection at a large refugee shelter in Toronto, April 2020: a clinical and epidemiologic descriptive analysis.
Redditt V; Wright V; Rashid M; Male R; Bogoch I
CMAJ Open; 2020; 8(4):E819-E824. PubMed ID: 33293331
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.
D'Souza G; Tong W; Gustafson D; Alcaide ML; Lahiri CD; Sharma A; French AL; Palella FJ; Kempf MC; Mimiaga MJ; Ramirez C; Kassaye S; Rinaldo CR; Brown TT; Tien PC; Adimora AA
J Acquir Immune Defic Syndr; 2022 Jan; 89(1):1-8. PubMed ID: 34878431
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.
Wohl DA; Barzin AH; Napravnik S; Davy-Mendez T; Smedberg JR; Thompson CM; Ruegsegger L; Gilleskie M; Weber DJ; Whinna HC; Miller MB
PLoS One; 2021; 16(12):e0260879. PubMed ID: 34890441
[TBL] [Abstract][Full Text] [Related]
16. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
[TBL] [Abstract][Full Text] [Related]
17. Identifying COVID-19 cases in outpatient settings.
Mao Y; Tan YR; Thein TL; Chai YAL; Cook AR; Dickens BL; Lew YJ; Lim FS; Lim JT; Sun Y; Sundaram M; Soh A; Tan GSE; Wong FPG; Young B; Zeng K; Chen M; Ong DLS
Epidemiol Infect; 2021 Apr; 149():e92. PubMed ID: 33814027
[TBL] [Abstract][Full Text] [Related]
18. High Sensitivity and NPV for BinaxNOW Rapid Antigen Test in Children at a Mass Testing Site during Prevalent Delta Variant Period.
Sun KJ; Vaeth MJE; Robinson M; Elhabashy M; Gupta I; Purekal S; Hammershaimb EA; Peralta R; Mitchell A; Foyez M; Johnson JK; Ficke JR; Manabe YC; Campbell JD; Callahan CW; Locke CF; Kantsiper M; ; Siddiqui ZK
Microbiol Spectr; 2022 Aug; 10(4):e0023622. PubMed ID: 35867409
[TBL] [Abstract][Full Text] [Related]
19. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian KK; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
PLoS One; 2021; 16(3):e0241875. PubMed ID: 33760821
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of symptoms for pediatric SARS-CoV-2 infection in a primary care setting.
Weng CH; Butt WWW; Brooks MB; Clarke C; Jenkins HE; Holland SD; Chiang SS
PLoS One; 2021; 16(12):e0249980. PubMed ID: 34898635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
